Metraipolis › archive › dc_279bef30b87b
Angiotensin-Converting Enzyme Inhibitors to Prevent Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Scientific Speculation or an… — Europe PMC PMID:41465213
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41465213
- DOI
- 10.3390/ijms262411782
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T21:39:32.980Z
- SHA-256 of the archived text
54af4bedd73965e04dbab97e1543a3a8d292b23993393b1673b5b420e6a05a59- Stable URL of this page
https://metraipolis.com/documento/dc_279bef30b87b
How to cite
Angiotensin-Converting Enzyme Inhibitors to Prevent Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Scientific Speculation or an… — Europe PMC PMID:41465213 — Europe PMC (en), https://europepmc.org/article/MED/41465213 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_279bef30b87b (Metraipolis archive dc_279bef30b87b, sha256 54af4bedd73965e04dbab97e1543a3a8d292b23993393b1673b5b420e6a05a59)
BibTeX
@misc{dc279bef30b87b,
title = {Angiotensin-Converting Enzyme Inhibitors to Prevent Liver Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: Scientific Speculation or an… — Europe PMC PMID:41465213},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41465213},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_279bef30b87b; sha256 54af4bedd73965e04dbab97e1543a3a8d292b23993393b1673b5b420e6a05a59},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41465213. Agents can read the archived copy with the MCP tool read_document.